[Connection between caffeine, adenosine receptors and dopamine. Coffee reduces the risk of Parkinson disease].
Fredholm
Bertil B
BB
Institutionen för fysiologi och farmakologi, Karolinska institutet, Stockholm. bertil.fredholm@fyfa.ki.se
D058917:Adenosine A2 Receptor Antagonists; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000502:physiology; D002110:Caffeine / Q000008:administration & dosage*; D003069:Coffee; D006801:Humans; D010300:Parkinson Disease / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D043705:Receptor, Adenosine A2A / Q000187:drug effects* / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000187:drug effects* / Q000502:physiology
D058917:Adenosine A2 Receptor Antagonists; D003069:Coffee; D043705:Receptor, Adenosine A2A; D017448:Receptors, Dopamine D2; D002110:Caffeine
Samband mellan koffein, adenosinreceptorer och dopamin. Kaffe minskar risk för Parkinsons sjukdom.